Navigation Links
VIVUS Provides Regulatory Update on QNEXA NDA
Date:1/21/2011

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity.  The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.  At this meeting the FDA requested that VIVUS assess the feasibility of analyzing existing healthcare databases to determine the historical incidence of oral cleft in offspring of women treated with topiramate for migraine prophylaxis (100 mg).

Based on discussions at the meeting, VIVUS believes the FDA's additional request stems from two published reports which cited two oral clefts in the UK Epilepsy and Pregnancy Register (Hunt et al., July 2008) and four, including two isolated cleft lips, from the North American AED Pregnancy Registry (Hernandez-Diaz et al., June 2010).  In the QNEXA® studies, which included 15 births from women exposed to QNEXA® or topiramate, there were no reports of any fetal malformations. The timing of the planned resubmission of the QNEXA® NDA will be determined after agreement with the FDA is reached on the feasibility assessment.  VIVUS anticipates continued dialog with the FDA on the planned resubmission of the QNEXA® NDA.

About QNEXA® Controlled Release Capsules QNEXA® [kyoo-nek-suh] is an investigational drug being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA® is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which together decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
2. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
3. VIVUS to Present at Two Upcoming Investor Conferences
4. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
5. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
6. VIVUS Announces Sale of MUSE Assets to Meda
7. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
8. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
9. VIVUS to Present at Lazard Capital Markets Healthcare Conference
10. VIVUS Announces Promotion of Peter Tam to President
11. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Medical Science ... As the key link between the medical device industry ... even more in the coming years as the device ... According to research by benchmarking firm, Best ... can gain an important edge is by harnessing new ...
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today issued the following open letter to shareholders ... Dr. Med. Sc. Dear RXi Shareholders, ... number of inaccurate statements posted on certain social ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... N.C., Oct. 29 Cempra Pharmaceuticals today announced a ... Infectious Diseases Society of America, 47th Annual Meeting, October ... of CEM-101 and more than 25 other antibiotics was ... collected in 2008 from medical centers in the U.S., ...
... Calif., Oct. 28 Infor-Med Corporation, makers of Praxis ... of Praxis Version 5 featuring Datum, a tool that ... and share discrete clinical data. The Praxis Datum engine ... designed to meet future ,meaningful use, guidelines. , With ...
Cached Medicine Technology:Data Presented on Cempra Pharmaceutical's CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates 2Praxis Electronic Medical Records Announces New Version 5 With Breakthrough in EHR Documentation 2
(Date:12/26/2014)... (PRWEB) December 26, 2014 Cooking ... of 3.1 out of 5. This score reflects slightly ... level of product specialization, low switching costs and a ... reduced by the low availability of substitutes for cooking ... price of steel and aluminum, key inputs in the ...
(Date:12/26/2014)... FL (PRWEB) December 26, 2014 India ... health insurance in the USA, announced today a new ... assist members in choosing the right plan for their ... the complexity out of the selection process when choosing ... by age group with only a few clicks. Many ...
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the business is ... company announces big discounts on its bamboo mats , ... is the world’s leader in bamboo flooring. According to ... 20, 2015. , The bamboo mats are made from ... All the bamboo strips for the mats are boiled ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... , ... Panama City, Fla. (PRWEB)July ... today announced AdvancedSMAT™, an innovative tool that helps healthcare organizations ... functionality. AdvancedSMAT saves time and improves searching efficiencies by offering ...
... July 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), ... research,and development outsourcing company with operations in ... Dr. Richard M. Soll has joined WuXi ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), As ...
... Latinos with tools to lead a healthy ... ... with the National Council of La Raza (NCLR) to unveil a small,tool aimed ... 148-page pocket-sized health book, Buena Salud, Buena Vida --,Su Guia de Recursos de ...
... which can cause skin cancer , , SUNDAY, July 13 (HealthDay ... people use as the summer sun rises high and threatens ... are not only painful, they can lead to skin cancer, ... , But, new research has led some to question the ...
... and staff of the,American Heart Association extend their sympathy ... died yesterday at the age of 99., "Michael ... responsible for developing the field of cardiovascular surgery,",said Timothy ... started surgery of the aorta, the main artery in ...
... LOUISVILLE, Ky., July 12 Dave Robert,Armstrong, a 32-year-old ... around the world by receiving a hand transplant today, ... Hand Care Center by,Kleinert Kutz and University of Louisville ... at approximately 2:08 a.m. (EDT),today involved a six-member hand ...
Cached Medicine News:Health News:Noesis Health Introduces AdvancedSMAT for Better Management of Cloverleaf Message Files 2Health News:Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 4Health News:Are You Getting Burned by Your Sunscreen? 2Health News:Are You Getting Burned by Your Sunscreen? 3Health News:American Heart Association Saddened by Death of Surgical Pioneer Michael E. DeBakey 2Health News:Nation's Fourth Hand Transplant Performed at Jewish Hospital Hand Care Center by Kleinert Kutz and University of Louisville Surgeons 2Health News:Nation's Fourth Hand Transplant Performed at Jewish Hospital Hand Care Center by Kleinert Kutz and University of Louisville Surgeons 3
Angled shafts with 9 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left....
Shafts angled 45 degrees, 10 mm from tip to bend. Tips curved with 0.5 mm, 1 x 2 teeth. Serrated handle with polished finish....
Smooth pointed tips open to 3.0 mm. 45 degree cross action angled shafts. Tip to Angle Length: 12.0 mm. Round handle....
Curved shafts with fine pointed tips. Smooth handle with dull finish....
Medicine Products: